009-Neuromodulation Vs Neurotransmission-V5

Total Page：16

File Type：pdf, Size：1020Kb

009-Neuromodulation Vs Neurotransmission-V5

Neurotransmission is the process by which an incoming electrical signal, or action potential, in a neuron is conveted into a chemical message at the synapse. 1 Vesicles containing molecules of neurotransmiter dump their cargo into the synaptic clet . The molecules then bind to their receptors on the postsynaptic GLUTAMATE* GABA ACETYLCHOLINE SEROTONIN ACETYLCHOLINE SEROTONIN DOPAMINE NORADRENALINE HISTAMINE membrane and induce their eect, usually the opening of postsynaptic ligand-gated ion channels and the excitation, or inhibition, of the postsynaptic neuron. Excitatoy amino acid Inhibitoy amino acid Acts as a Acts as a A neuromodulator in A neuromodulator in Impotant NOREPINEPHRINE Neuromodulator neurotransmiter neurotransmiter, neurotransmiter in neurotransmiter in the central nevous the central nevous neuromodulator for Impotant neuromodulator involved in THIS RAPID SIGNALLING MECHANISM TAKES PLACE ON THE MILLISECOND TIMESCALE. ubiquitous throughout the activates GABA the peripheral nevous the peripheral nevous system involved in system than has been movement, dopaminergic of wakefulness and arousal. wakefulness and brain, activates NMDA, receptors throughout system causing system. behaviors related to identiied as impotant cells are concentrated in In the sympathetic nevous aletness. AMPA and kainate the brain, causing muscles to contract. drug abuse, atention, for regulating sleep the basal ganglia. Also system, noradrenaline receptors. hyperpolarisation and food intake, and qualiy, mood, impotant for enhancing regulates heat rate and Neuromodulation is a slower mechanism by which molecules of neuromodulators are released by neurons at a synapse, but act on G-protein coupled *Also a neuromodulator via inhibition of the memoy. depression and anxiey. addictive behaviors. blood pressure. metabotropic glutamate postsynaptic neuron. receptors and voltage-gated ion channels on the postsynaptic neuron to modulate its activiy. Neuromodulation is a change in the state of a neuron, or group receptors of neurons, which alters its response to subsequent stimulation². They are also diusible and can act at adjacent synapses. References THIS SLOWER SIGNALLING MECHANISM TAKES PLACE OVER SECONDS TO MINUTES. 1. Fat, P., & Katz, B. (1952). Spontaneous subthreshold activiy at motor neve endings. The Journal of physiology, 117(1), 109-128. 2. Piccioto, M. R., Higley, M. J., & Mineur, Y. S. (2012). Aceylcholine as a neuromodulator: cholinergic signaling shapes nevous system function and behavior. Neuron, 76(1), 116-129. 3. Passani, M. B., Panula, P., & Lin, J. S. (2014). Histamine in the brain. Frontiers in systems neuroscience, 8, 64. 4. htp://www.brainfacts.org/brain-anatomy-and-function/cells-and-circuits/2012/classical-neurotransmiters-brain-communicators. accessed 3/2018.

Copy Link

Recommended publications

Modulation of Interhemispheric Inhibition Between Primary Motor Cortices Induced by Manual Motor Imitation: a Transcranial Magnetic Stimulation Study
brain sciences Article Modulation of Interhemispheric Inhibition between Primary Motor Cortices Induced by Manual Motor Imitation: A Transcranial Magnetic Stimulation Study Dongting Tian 1,*, Shin-ichi Izumi 1,2 and Eizaburo Suzuki 1,3 1 Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan; [email protected] (S.-i.I.); [email protected] (E.S.) 2 Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Biomedical Engineering, Sendai 980-8575, Japan 3 Department of Physical Therapy, Yamagata Prefectural University of Health Sciences, 260 Kamiyanagi, Yamagata 990-2212, Japan * Correspondence: [email protected] Abstract: Imitation has been proven effective in motor development and neurorehabilitation. How- ever, the relationship between imitation and interhemispheric inhibition (IHI) remains unclear. Transcranial magnetic stimulation (TMS) can be used to investigate IHI. In this study, the modiﬁca- tion effects of IHI resulting from mirror neuron system (MNS) activation during different imitations are addressed. We measured IHI between homologous primary motor cortex (M1) by analyzing the ipsilateral silent period (iSP) evoked by single-pulse focal TMS during imitation and analyzed the respective IHI modulation during and after different patterns of imitation. Our main results showed that throughout anatomical imitation, signiﬁcant time-course changes of iSP duration through the Citation: Tian, D.; Izumi, S.-i.; experiment were observed in both directions. iSP duration declined from the pre-imitation time Suzuki, E. Modulation of Interhemispheric Inhibition between point to the post-imitation time point and did not return to baseline after 30 min rest.
[Show full text]
Molecular Biology of Neuronal Voltage-Gated Calcium Channels
EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 30, No 3, 123-130, September 1998 Molecular biology of neuronal voltage-gated calcium channels Hemin Chin and is capable of directing expression of calcium channel activity in heterologous expression systems. In the central Genetics Research Branch, Division of Basic and Clinical Neuroscience Research, nervous system (CNS), VGCCs are expressed by five National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, distinct a1 subunit genes (α1A, α1B, α1C, α1D and α1E), U.S.A. which exhibit further variations due to alternative splicing of the primary RNA transcripts. The α1C and, α1D su b u n i t Accepted 3 August 1998 genes encode dihydropyridine (DHP)-sensitive L-type channels, while the three other α1 subunit genes (α1A, α1B and α1E) give rise to DHP-insensitive P/Q-, N- and R-type channels, respectively. The α2 and δ s u b u n i t proteins are produced by proteolytic cleavage of a larger precursor produced by the single α2-δ gene (Table 1). Introduction Three alternatively spliced variants of the α2 subunit are expressed in a tissue-specific manner. Two variants Calcium ions are important intracellular messengers have been isolated from the brain and skeletal muscle mediating a number of neuronal functions including neuro- (Kim et al., 1992; Williams et al., 1992), and a distinct transmitter release, neurosecretion, neuronal excitation, third splice variant which is expressed in glial cells has survival of eurons, and regulation of gene expression. been recently identified (Puro et al., 1996). In addition to The entry of calcium across the plasmamembrane in the gene encoding the skeletal muscle β subunit, three response to membrane depolarization or activation of 1 other β subunit genes (β2, β3 and β4) have been isolated neurotransmitter receptors represents a major pathway thus far.
[Show full text]
Chemical Neurotransmission
Cambridge University Press 978-1-107-02598-1 — Stahl's Essential Psychopharmacology 4th Edition Excerpt More Information Chapter1 Chemical neurotransmission Anatomical versus chemical basis of Beyond the second messenger to a neurotransmission 1 phosphoprotein cascade triggering gene 16 Principles of chemical neurotransmission 5 expression Neurotransmitters 5 How neurotransmission triggers gene 18 Neurotransmission: classic, retrograde, expression 18 and volume 6 Molecular mechanism of gene expression Excitation–secretion coupling 8 Epigenetics 24 Signal transduction cascades 9 What are the molecular mechanisms 24 Overview 9 of epigenetics? Forming a second messenger 11 How epigenetics maintains or changes the status quo 26 Beyond the second messenger to phosphoprotein messengers 13 Summary 26 Modern psychopharmacology is largely the story of neurons, not unlike millions of telephone wires chemical neurotransmission. To understand the actions within thousands upon thousands of cables. The ana- of drugs on the brain, to grasp the impact of diseases tomically addressed brain is thus a complex wiring upon the central nervous system, and to interpret the diagram, ferrying electrical impulses to wherever behavioral consequences of psychiatric medicines, the “wire” is plugged in (i.e., at a synapse). Synapses one must be fluent in the language and principles of canformonmanypartsofaneuron,notjustthe chemical neurotransmission. The importance of this dendrites as axodendritic synapses, but also on the fact cannot be overstated for the student of psychophar- soma as axosomatic synapses, and even at the begin- macology. This chapter forms the foundation for the ning and at the end of axons (axoaxonic synapses) entire book, and the roadmap for one’s journey through (Figure 1-2).
[Show full text]
Systematic Examination of Low-Intensity Ultrasound Parameters
TOOLS AND RESOURCES Systematic examination of low-intensity ultrasound parameters on human motor cortex excitability and behavior Anton Fomenko1†*, Kai-Hsiang Stanley Chen1,2†, Jean-Franc¸ois Nankoo1, James Saravanamuttu1, Yanqiu Wang1, Mazen El-Baba1, Xue Xia3, Shakthi Sanjana Seerala4, Kullervo Hynynen4, Andres M Lozano1,5*, Robert Chen1,3* 1Krembil Research Institute, University Health Network, Toronto, Canada; 2Department of Neurology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan; 3Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada; 4Sunnybrook Research Institute, Toronto, Canada; 5Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, University of Toronto, Toronto, Canada Abstract Low-intensity transcranial ultrasound (TUS) can non-invasively modulate human neural activity. We investigated how different fundamental sonication parameters influence the effects of TUS on the motor cortex (M1) of 16 healthy subjects by probing cortico-cortical excitability and behavior. A low-intensity 500 kHz TUS transducer was coupled to a transcranial magnetic stimulation (TMS) coil. TMS was delivered 10 ms before the end of TUS to the left M1 hotspot of the first dorsal interosseous muscle. Varying acoustic parameters (pulse repetition frequency, duty *For correspondence: cycle, and sonication duration) on motor-evoked potential amplitude were examined. Paired-pulse [email protected] measures of cortical inhibition and facilitation, and performance on a visuomotor task was also (AF); assessed. TUS safely suppressed TMS-elicited motor cortical activity, with longer sonication [email protected] (AML); durations and shorter duty cycles when delivered in a blocked paradigm. TUS increased GABA - [email protected] (RC) A mediated short-interval intracortical inhibition and decreased reaction time on visuomotor task but † These authors contributed not when controlled with TUS at near-somatosensory threshold intensity.
[Show full text]
Development and Prospect of Neuromodulation Technology
Development and Prospect of Neuromodulation Technology Hsin-Yi (Happy) Lai, PI Professor 赖欣怡, 教授 Why Study the Brain? SpiNNaker Chip 80-90 billion Neurons Robot Brain Disease Understanding Human Mind and Brain Function Neuroscience-inspired Artificial Intelligence New Diagnosis and Treatments for Brain Disease Brain Machine Interface Brain Stimulation chiefscientist.gov.au; www.swisswuff.ch; queuesquared.com; cannabisoilresearch.com; Johns Hopkins Applied Physics Lab Sensations, Memory, Emotion… Vision http://faculty.pasadena.edu/ How to Study the Brain? Brain Machine Interface Recording Neuromodulation Technology Brain Research Technology Medical Science Diagnosis and Therapy Neuromodulation Technology Electrical (DBS) Chemical Thermal Cryogenic Optical Magnetic (TMS) Mechanical (FUS) Invasive Neuromodulation Optical stimulation Microinjection Deep brain stimulation (DBS) http://www.tritechresearch.com/IMS-3.html Reversible cooling • targeting accuracy • brain tissue damage, adverse side effects http:// www.the-scientist.com • Any new applications for other brain diseases and disorder? Ex: Epilepsy, Dysmyotonia, Obsessive, Depression, etc. Sumner et al., Nat Neuroscience, 2008 https://www.youtube.com/watch?v=7Mmsah0v9Qc Noninvasive Neuromodulation Transcranial magnetic Transcranial direct stimulation (TMS) current stimulation (tDCS) http://www.drchugh.com/rtms.html 1–2 mA http://davidileitman.com/time-causality-and-perception-tcp/ neurology and mental health cognitive functions Limitation of spatial resolution !!! Noninvasive Neuromodulation Temporal interference Focused ultrasound (FUS) stimulation (TIS) Using TMS or TIS to directly stimulate deep brain structures requires stronger stimulation of overlying (eg, cortical) areas, which may result in unanticipated adverse effects and encroach on safety guidelines. Alan Urban, et al, 2015 Nature Meth Dmochowski et al., 2017 Cell • high spatial selectivity TIS in humans is a challenging • penetration depth and promising technique.
[Show full text]
Part III: Modeling Neurotransmission – a Cholinergic Synapse
Part III: Modeling Neurotransmission – A Cholinergic Synapse Operation of the nervous system is dependent on the flow of information through chains of neurons functionally connected by synapses. The neuron conducting impulses toward the synapse is the presynaptic neuron, and the neuron transmitting the signal away from the synapse is the postsynaptic neuron. Chemical synapses are specialized for release and reception of chemical neurotransmitters. For the most part, neurotransmitter receptors in the membrane of the postsynaptic cell are either 1.) channel-linked receptors, which mediate fast synaptic transmission, or 2.) G protein-linked receptors, which oversee slow synaptic responses. Channel-linked receptors are ligand-gated ion channels that interact directly with a neurotransmitter and are called ionotropic receptors. Alternatively, metabotropic receptors do not have a channel that opens or closes but rather, are linked to a G-protein. Once the neurotransmitter binds to the metabotropic receptor, the receptor activates the G-protein which, in turn, goes on to activate another molecule. 3a. Model the ionotropic cholinergic synapse shown below. Be sure to label all of the following: voltage-gated sodium channel, voltage-gated potassium channel, neurotransmitter, synaptic vesicle, presynaptic cell, postsynaptic cell, potassium leak channel, sodium-potassium pump, synaptic cleft, acetylcholine receptor, acetylcholinesterase, calcium channel. When a nerve impulse (action potential) reaches the axon terminal, it sets into motion a chain of events that triggers the release of neurotransmitter. You will next model the events of neurotransmission at a cholinergic synapse. Cholinergic synapses utilize acetylcholine as the chemical of neurotransmission. MSOE Center for BioMolecular Modeling Synapse Kit: Section 3-6 | 1 Step 1 - Action potential arrives at the Step 2 - Calcium channels open in the terminal end of the presynaptic cell.
[Show full text]
Regulation of Neuronal Communication by G Protein-Coupled Receptors ⇑ Yunhong Huang, Amantha Thathiah
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 589 (2015) 1607–1619 journal homepage: www.FEBSLetters.org Review Regulation of neuronal communication by G protein-coupled receptors ⇑ Yunhong Huang, Amantha Thathiah VIB Center for the Biology of Disease, Leuven, Belgium Center for Human Genetics (CME) and Leuven Institute for Neurodegenerative Diseases (LIND), University of Leuven (KUL), Leuven, Belgium article info abstract Article history: Neuronal communication plays an essential role in the propagation of information in the brain and Received 31 March 2015 requires a precisely orchestrated connectivity between neurons. Synaptic transmission is the mech- Revised 5 May 2015 anism through which neurons communicate with each other. It is a strictly regulated process which Accepted 5 May 2015 involves membrane depolarization, the cellular exocytosis machinery, neurotransmitter release Available online 14 May 2015 from synaptic vesicles into the synaptic cleft, and the interaction between ion channels, G Edited by Wilhelm Just protein-coupled receptors (GPCRs), and downstream effector molecules. The focus of this review is to explore the role of GPCRs and G protein-signaling in neurotransmission, to highlight the func- tion of GPCRs, which are localized in both presynaptic and postsynaptic membrane terminals, in reg- Keywords: G protein-coupled receptors ulation of intrasynaptic and intersynaptic communication, and to discuss the involvement of G-proteins astrocytic GPCRs in the regulation of neuronal communication. Neuronal communication Ó 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. Synaptic transmission Signaling Astrocytes Neurons Autoreceptors Neurotransmitters 1.
[Show full text]
RIM-BP2 Primes Synaptic Vesicles Via Recruitment of Munc13-1 At
RESEARCH ARTICLE RIM-BP2 primes synaptic vesicles via recruitment of Munc13-1 at hippocampal mossy fiber synapses Marisa M Brockmann1†, Marta Maglione2,3,4†, Claudia G Willmes5†, Alexander Stumpf6, Boris A Bouazza1, Laura M Velasquez6, M Katharina Grauel1, Prateep Beed6, Martin Lehmann3, Niclas Gimber6, Jan Schmoranzer4, Stephan J Sigrist2,4,5*, Christian Rosenmund1,4*, Dietmar Schmitz4,5,6* 1Institut fu¨ r Neurophysiologie, Charite´ – Universita¨ tsmedizin Berlin, corporate member of Freie Universita¨ t Berlin, Humboldt-Universita¨ t zu Berlin, and Berlin Institute of Health, Berlin, Germany; 2Freie Universita¨ t Berlin, Institut fu¨ r Biologie, Berlin, Germany; 3Leibniz-Forschungsinstitut fu¨ r Molekulare Pharmakologie (FMP), Berlin, Germany; 4NeuroCure Cluster of Excellence, Berlin, Germany; 5DZNE, German Center for Neurodegenerative Diseases, Berlin, Germany; 6Neuroscience Research Center, Charite´ – Universita¨ tsmedizin Berlin, corporate member of Freie Universita¨ t Berlin, Humboldt-Universita¨ t zu Berlin, and Berlin Institute of Health, Berlin, Germany Abstract All synapses require fusion-competent vesicles and coordinated Ca2+-secretion coupling for neurotransmission, yet functional and anatomical properties are diverse across *For correspondence: different synapse types. We show that the presynaptic protein RIM-BP2 has diversified functions in [email protected] (SJS); neurotransmitter release at different central murine synapses and thus contributes to synaptic [email protected] diversity. At hippocampal pyramidal CA3-CA1 synapses, RIM-BP2 loss has a mild effect on (CR); neurotransmitter release, by only regulating Ca2+-secretion coupling. However, at hippocampal [email protected] (DS) mossy fiber synapses, RIM-BP2 has a substantial impact on neurotransmitter release by promoting †These authors contributed vesicle docking/priming and vesicular release probability via stabilization of Munc13-1 at the active equally to this work zone.
[Show full text]
Challenges in Neuromodulation Therapy
Challenges in Neuromodulation Therapy Milton M. Morris, PhD, MBA Principal MEH BioMedical, LLC February 25, 2015 Neuromodulation offers multiple indication therapy EMERGING Deep Brain Stim: Obesity, Stroke Recovery, Depression FDA APPROVED Cortical Stim: Epilepsy Deep Brain Stim: Peripheral Nerve Stim: Migraines, Extremity Pain Parkinson’s Disease, Dystonia, Essential Tremor, Obsessive Compulsive Disorder Carotid Artery, Sinus Stim: Hypertension Vagus Nerve Stimulation: Hypoglossal & Phrenic Nerve Stim: Sleep Apnea Depression, Epilepsy Spinal Cord: Spinal Cord Stim: Angina Pain Gastric Stim: Obesity Sacral Nerve Stim: Sacral & Pudendal Nerve Stim: Urinary Incontinence, Interstitial Cystitis, Sexual Function, Pelvic Pain Fecal Incontinence Percutaneous Tibial Nerve Stim: FUTURE Urinary Incontinence Deep Brain Stim: Alzheimer’s, Anxiety, Bulimia, Tinnitus, Traumatic Brain Injury, Tourette’s, Sleep Disorders, Autism, Bipolar Vagus Nerve Stim: Alzheimer’s, Anxiety, Obesity, Bulimia, Tinnitus, Obsessive Compulsive Disorder, Heart Failure Spinal Cord Stim: Asthma Gastric Stim: Bulimia, Interstitial Cystitis Status of Neuromodulation Therapy(ies) • FDA: Approved Epilepsy by the numbers • CMS: Favorable Coverage Recommendation Epilepsy 9 <3% chance of seizure th 4 most common MILLION freedom after 2 AED neurological disease after People living with epilepsy in migraine, stroke and failures United States, Europe, Alzheimer's disease and Japan Direct and indirect costs 400,000 of 25-40X People indicated for Mortality rate vs. VNS Therapy® $13.5B general population in US per year in US alone Source: CDC, WHO, IOC report on Epilepsy Status of Neuromodulation Therapy(ies) • FDA: Approved (VNS) Depression by the numbers • CMS: Non-Favorable Coverage Recommendation Depression 18 350 Major depressive MILLION Million disorder (MDD) is the People affected at any People worldwide second leading cause of one time in United affected by depressive disability worldwide* States illness 4 Direct and indirect costs of >39,000 Million > $43B Suicide deaths per year approx.
[Show full text]
G-Protein-Coupled Receptors in CNS: a Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits
cells Review G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits Shofiul Azam 1 , Md. Ezazul Haque 1, Md. Jakaria 1,2 , Song-Hee Jo 1, In-Su Kim 3,* and Dong-Kug Choi 1,3,* 1 Department of Applied Life Science & Integrated Bioscience, Graduate School, Konkuk University, Chungju 27478, Korea; shofi[email protected] (S.A.); [email protected] (M.E.H.); md.jakaria@florey.edu.au (M.J.); [email protected] (S.-H.J.) 2 The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3010, Australia 3 Department of Integrated Bioscience & Biotechnology, College of Biomedical and Health Science, and Research Institute of Inflammatory Disease (RID), Konkuk University, Chungju 27478, Korea * Correspondence: [email protected] (I.-S.K.); [email protected] (D.-K.C.); Tel.: +82-010-3876-4773 (I.-S.K.); +82-43-840-3610 (D.-K.C.); Fax: +82-43-840-3872 (D.-K.C.) Received: 16 January 2020; Accepted: 18 February 2020; Published: 23 February 2020 Abstract: Neurodegenerative diseases are a large group of neurological disorders with diverse etiological and pathological phenomena. However, current therapeutics rely mostly on symptomatic relief while failing to target the underlying disease pathobiology. G-protein-coupled receptors (GPCRs) are one of the most frequently targeted receptors for developing novel therapeutics for central nervous system (CNS) disorders. Many currently available antipsychotic therapeutics also act as either antagonists or agonists of different GPCRs. Therefore, GPCR-based drug development is spreading widely to regulate neurodegeneration and associated cognitive deficits through the modulation of canonical and noncanonical signals.
[Show full text]
The Mechanisms and Functions of Spontaneous Neurotransmitter Release
REVIEWS The mechanisms and functions of spontaneous neurotransmitter release Ege T. Kavalali Abstract | Fast synaptic communication in the brain requires synchronous vesicle fusion that is evoked by action potential-induced Ca2+ influx. However, synaptic terminals also release neurotransmitters by spontaneous vesicle fusion, which is independent of presynaptic action potentials. A functional role for spontaneous neurotransmitter release events in the regulation of synaptic plasticity and homeostasis, as well as the regulation of certain behaviours, has been reported. In addition, there is evidence that the presynaptic mechanisms underlying spontaneous release of neurotransmitters and their postsynaptic targets are segregated from those of evoked neurotransmission. These findings challenge current assumptions about neuronal signalling and neurotransmission, as they indicate that spontaneous neurotransmission has an autonomous role in interneuronal communication that is distinct from that of evoked release. 10–13 Docked vesicles Our current insights into the mechanisms underlying relatively intact . Thus, although these experiments Synaptic vesicles that are synaptic transmission originate from experiments that proved the vesicular hypothesis of neurotransmitter tethered to the presynaptic were conducted in the 1950s by Bernard Katz and col- release, they raised the question of whether spontane- membrane or the active zone leagues1–3 (FIG. 1). A key aspect of these studies was the ous release events originate from the same vesicular traf- structure. According to current discovery of spontaneous neurotransmitter release ficking pathway as evoked neurotransmission14. Recent views, not all docked vesicles are fully primed for fusion and events, which seemed to occur in discrete ‘quantal’ advances in our understanding support the autonomous release of neurotransmitter. packets (FIG.
[Show full text]
10 Things to Know About Neuromodulation. Minimally Invasive Procedures to Reduce Or Alleviate Pain
NORTH AMERICAN NEUROMODULATION SOCIETY 4700 W. Lake Avenue Glenview, IL 60025 www.neuromodulation.org Rubenstein Public Relations Contact: Eve McGrath Tel: 212-843-8490 Email: [email protected] FOR IMMEDIATE RELEASE 10 Things to Know About Neuromodulation Minimally Invasive Procedures to Reduce or Alleviate Pain NEW YORK – February 24, 2010 – Robert Foreman, Ph.D., president of the North American Neuromodulation Society (NANS), stated, “Neuromodulation is among the most rapidly growing fields in medicine today. It can help to relieve chronic back pain, pain from cancer and other nerve injuries, pain from Complex Regional Pain Syndrome (CRPS) and Reflex Sympathetic Dystrophy (RSD) greatly improving the quality of life for patients.” Neuromodulation encompasses the application of targeted electrical, chemical and biological technologies to the nervous system in order to improve function and quality of life. The appropriate therapy (low level electrical pulses or micro-doses of medicine) are targeted to nerves along the spinal cord to block pain signals to the brain According to Joshua Prager, MD, MS, former president of NANS, “Neuromodulation can give people their lives back. Patients have gone from wheelchairs back to the tennis court, back to the sidelines of their children’s soccer games, back to their jobs. There are few treatments that can improve the activity level and the psychological outlook of a patient in pain like neuromodulation techniques.” NANS has compiled ten things everyone should know about neuromodulation: 1. Neuromodulation alleviates or lessens pain without putting patients into a “drug fog.” By relieving pain with neuro-stimulation or a drug-delivery system, that provides micro- doses of medicine, the patient can avoid some side effects, including excessive sedation or clouding of thoughts.
[Show full text]